|
Volumn 109, Issue 25, 2004, Pages 3202-3207
|
Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
3,4 DIHYDROXYPHENYLETHYLENE GLYCOL;
4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL;
ADRENERGIC RECEPTOR AFFECTING AGENT;
COTRANSPORTER;
DIAGNOSTIC AGENT;
DRUG DERIVATIVE;
DULOXETINE;
NORADRENALIN;
NORADRENALIN TRANSPORTER;
SLC6A2 PROTEIN, HUMAN;
THIOPHENE DERIVATIVE;
TYRAMINE;
ADOLESCENT;
ADULT;
ARTICLE;
BLOOD;
BODY POSTURE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
FEMALE;
HEART RATE;
HUMAN;
MALE;
RADIOASSAY;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY AND SPECIFICITY;
SYSTOLE;
URINE;
ADOLESCENT;
ADRENERGIC UPTAKE INHIBITORS;
ADULT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HEART RATE;
HUMANS;
MALE;
METHOXYHYDROXYPHENYLGLYCOL;
NOREPINEPHRINE;
NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;
POSTURE;
RADIOLIGAND ASSAY;
SENSITIVITY AND SPECIFICITY;
SYMPORTERS;
SYSTOLE;
THIOPHENES;
TYRAMINE;
|
EID: 4444224449
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.CIR.0000130847.18666.39 Document Type: Article |
Times cited : (88)
|
References (0)
|